SCHEMBL6015437

SCHEMBL6015437

CCCCOC(=O)NC(CC(=O)O)c1c(C)cc(O)cc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.41
SMN1; SMN2 Q16637 8/20 0.41
RAB9A P51151 7/20 0.41
NPC1 O15118 6/20 0.41
HPGD P15428 5/20 0.41
CYP1A2 P05177 4/20 0.41
CYP2C19 P33261 4/20 0.41
CYP2C9 P11712 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
MAPK1 P28482 3/20 0.40
ALDH1A1 P00352 2/20 0.38
CASP1 P29466 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
MCL1 Q07820 1/20 0.38
LMNA P02545 3/20 0.37
CTSK P43235 1/20 0.37
CYP2D6 P10635 1/20 0.37
TSHR P16473 1/20 0.37
NR1H2 P55055 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5279762 0.87 SMN1; SMN2 (0.46) ESR1SMN1; SMN2RAB9ANPC1HPGD
SCHEMBL5089567 0.78 CTSA (0.54)
SCHEMBL6250233 0.78 FAAH (0.45) SMN1; SMN2RAB9ANPC1HPGDCYP1A2
SCHEMBL6251048 0.77 FAAH (0.41) SMN1; SMN2L3MBTL1MAPK1ALDH1A1LMNA
SCHEMBL5085765 0.77 SMN1; SMN2 (0.50) SMN1; SMN2RAB9ANPC1HPGDL3MBTL1
SCHEMBL844472 0.76 SMN1; SMN2 (0.57) SMN1; SMN2RAB9ANPC1HPGDCYP1A2
SCHEMBL14040614 0.76 SMN1; SMN2 (0.57) SMN1; SMN2RAB9ANPC1HPGDCYP1A2
SCHEMBL1721258 0.76 SMN1; SMN2 (0.39) ESR1SMN1; SMN2RAB9ANPC1HPGD
SCHEMBL2149058 0.76 FAAH (0.43) SMN1; SMN2RAB9ANPC1HPGDCYP1A2
SCHEMBL5276551 0.76 SMN1; SMN2 (0.45) ESR1SMN1; SMN2RAB9ANPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2573068-A1 Process for preparing intermediates of compounds useful as opioid receptor modulators Janssen Pharmaceutica NV (BE) 2013-03-27 EP disclosed
EP-1725537-A1 NOVEL COMPOUNDS AS OPIOID RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-11-29 EP disclosed
WO-2005090315-A1 NOVEL COMPOUNDS AS OPIOID RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, N. V. (BE) 2005-09-29 WO disclosed